Advertisement

Restless Legs Syndrome

  • Guy D. Leschziner
Chapter

Abstract

Restless legs syndrome is a common neurological disorder that is underdiagnosed in large part due to the myriad of presenting features. It is associated with significant morbidity, and early recognition and management can have a profound impact on quality of life. This chapter discusses the clinical features, epidemiology, pathophysiology and management of restless legs syndrome and outlines some of the major obstacles to successful treatment.

References

  1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health and International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101–19.CrossRefPubMedGoogle Scholar
  2. Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165(11):1286–92.CrossRefPubMedGoogle Scholar
  3. Allen RP, Chen C, Garcia-Borreguero D, Polo O, Dubrava S, Miceli J, Knapp L, Winkelman JW. Comparison of pregabalin with pramipexole for restless legs syndrome. N Engl J Med. 2014;370(7):621–31.CrossRefPubMedGoogle Scholar
  4. Bayard M, Bailey B, Acharya D, Ambreen F, Duggal S, Kaur T, Rahman ZU, Roller K, Tudiver F. Bupropion and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2011;24(4):422–8.CrossRefPubMedGoogle Scholar
  5. Cesnik E, Casetta I, Turri M, Govoni V, Granieri E, Strambi LF, Manconi M. Transient RLS during pregnancy is a risk factor for the chronic idiopathic form. Neurology. 2010;75(23):2117–20.CrossRefPubMedGoogle Scholar
  6. Chervin RD, Archbold KH, Dillon JE, Pituch KJ, Panahi P, Dahl RE, Guilleminault C. Associations between symptoms of inattention, hyperactivity, restless legs, and periodic leg movements. Sleep. 2002;25(2):213–8.PubMedGoogle Scholar
  7. Clardy SL, Earley CJ, Allen RP, Beard JL, Connor JR. Ferritin subunits in CSF are decreased in restless legs syndrome. J Lab Clin Med. 2006;147(2):67–73.CrossRefPubMedGoogle Scholar
  8. Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology. 2006;67(1):125–30.CrossRefPubMedGoogle Scholar
  9. Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Ondo WG, Earley CJ. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61(3):304–9.CrossRefPubMedGoogle Scholar
  10. Connor JR, Wang XS, Allen RP, Beard JL, Wiesinger JA, Felt BT, Earley CJ. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain. 2009;132(Pt 9):2403–12.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep. 2010;33(1):81–7.PubMedPubMedCentralGoogle Scholar
  12. Desai AV, Cherkas LF, Spector TD, Williams AJ. Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin study. Twin Res. 2004;7(6):589–95.CrossRefPubMedGoogle Scholar
  13. Earley CJ, Hyland K, Allen RP. Circadian changes in CSF dopaminergic measures in restless legs syndrome. Sleep Med. 2006;7(3):263–8.CrossRefPubMedGoogle Scholar
  14. Earley CJ, Silber MH. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med. 2010;11(9):807–15.CrossRefPubMedGoogle Scholar
  15. Earley CJ, Allen RP, Beard JL, Connor JR. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res. 2000a;62(5):623–8.CrossRefPubMedGoogle Scholar
  16. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000b;54(8):1698–700.CrossRefPubMedGoogle Scholar
  17. Ekbom K. Restless legs: a clinical study. Acta Med Scand. 1945;158(Suppl):1–122.Google Scholar
  18. Erikson KM, Jones BC, Beard JL. Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr. 2000;130(11):2831–7.CrossRefPubMedGoogle Scholar
  19. Garcia-Borreguero D, Stillman P, Benes H, Buschmann H, Chaudhuri KR, Gonzalez Rodriguez VM, Hogl B, Kohnen R, Monti GC, Stiasny-Kolster K, Trenkwalder C, Williams AM, Zucconi M. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurol. 2011;11:28.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Garcia-Borreguero D, Silber MH, Winkelman JW, Hogl B, Bainbridge J, Buchfuhrer M, Hadjigeorgiou G, Inoue Y, Manconi M, Oertel W, Ondo W, Winkelmann J, Allen RP. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 2016;21:1–11.CrossRefPubMedGoogle Scholar
  21. Hadjigeorgiou GM, Scarmeas N. Restless legs syndrome in the darkness of dementia. Sleep. 2015;38(3):333–4.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Happe S, Reese JP, Stiasny-Kolster K, Peglau I, Mayer G, Klotsche J, Giani G, Geraedts M, Trenkwalder C, Dodel R. Assessing health-related quality of life in patients with restless legs syndrome. Sleep Med. 2009;10(3):295–305.CrossRefPubMedGoogle Scholar
  23. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep. 1999;22(7):970–99.CrossRefPubMedGoogle Scholar
  24. Hening W, Allen RP, Tenzer P, Winkelman JW. Restless legs syndrome: demographics, presentation, and differential diagnosis. Geriatrics. 2007;62(9):26–9.PubMedGoogle Scholar
  25. Hening WA, Allen RP, Washburn M, Lesage SR, Earley CJ. The four diagnostic criteria for restless legs syndrome are unable to exclude confounding conditions (“mimics”). Sleep Med. 2009;10(9):976–81.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Holmes R, Tluk S, Metta V, Patel P, Rao R, Williams A, Chaudhuri KR. Nature and variants of idiopathic restless legs syndrome: observations from 152 patients referred to secondary care in the UK. J Neural Transm. 2007;114(7):929–34.CrossRefPubMedGoogle Scholar
  27. Hornyak M, Scholz H, Kohnen R, Bengel J, Kassubek J, Trenkwalder C. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications. Sleep Med Rev. 2014;18(2):153–64.CrossRefPubMedGoogle Scholar
  28. Iber C, Ancoli-Israel S, Chesson A, Quan SF. The AASM manual for the scoring of sleep and associates events: rules, terminology and technical specifications. Westchester, IL: American Academy of Sleep Medicine; 2007.Google Scholar
  29. Innes KE, Selfe TK, Agarwal P. Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review. Sleep Med Rev. 2012;16(4):309–39.CrossRefPubMedGoogle Scholar
  30. Kavanagh D, Siddiqui S, Geddes CC. Restless legs syndrome in patients on dialysis. Am J Kidney Dis. 2004;43(5):763–71.CrossRefPubMedGoogle Scholar
  31. Khan FH, Ahlberg CD, Chow CA, Shah DR, Koo BB. Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome. J Neurol. 2017;264(8):1634–41.CrossRefPubMedGoogle Scholar
  32. Lee JJ, Erdos J, Wilkosz MF, Laplante R, Wagoner B. Bupropion as a possible treatment option for restless legs syndrome. Ann Pharmacother. 2009;43(2):370–4.CrossRefPubMedGoogle Scholar
  33. Leschziner G, Gringras P. Restless legs syndrome. BMJ. 2012;344:E3056.CrossRefPubMedGoogle Scholar
  34. Mackie S, Winkelman JW. Long-term treatment of restless legs syndrome (RLS): an approach to management of worsening symptoms, loss of efficacy, and augmentation. CNS Drugs. 2015;29(5):351–7.CrossRefPubMedGoogle Scholar
  35. Manconi M, Govoni V, De Vito A, Economou NT, Cesnik E, Mollica G, Granieri E. Pregnancy as a risk factor for restless legs syndrome. Sleep Med. 2004;5(3):305–8.CrossRefPubMedGoogle Scholar
  36. Manconi M, Fulda S, Ferri R, Ferini-Strambi L, Bassetti CL. 7. Dissociation of periodic leg movements from arousals in restless legs syndrome. Clin Neurophysiol. 2012;123(10):E111.CrossRefGoogle Scholar
  37. Michaud M, Chabli A, Lavigne G, Montplaisir J. Arm restlessness in patients with restless legs syndrome. Mov Disord. 2000;15(2):289–93.CrossRefPubMedGoogle Scholar
  38. Mitchell UH. Nondrug-related aspect of treating Ekbom disease, formerly known as restless legs syndrome. Neuropsychiatr Dis Treat. 2011;7:251–7.CrossRefPubMedPubMedCentralGoogle Scholar
  39. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12(1):61–5.CrossRefPubMedGoogle Scholar
  40. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002;53(1):547–54.CrossRefPubMedGoogle Scholar
  41. Ohayon MM, O’hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16(4):283–95.CrossRefPubMedGoogle Scholar
  42. Ondo WG, Vuong KD, Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology. 2000;55(9):1404–6.CrossRefPubMedGoogle Scholar
  43. Perez-Diaz H, Iranzo A, Rye DB, Santamaria J. Restless abdomen: a phenotypic variant of restless legs syndrome. Neurology. 2011;77(13):1283–6.CrossRefPubMedGoogle Scholar
  44. Picchietti D, Allen RP, Walters AS, Davidson JE, Myers A, Ferini-Strambi L. Restless legs syndrome: prevalence and impact in children and adolescents—the Peds REST study. Pediatrics. 2007;120(2):253–66.CrossRefPubMedGoogle Scholar
  45. Rangarajan S, Rangarajan S, D’Souza GA. Restless legs syndrome in an Indian urban population. Sleep Med. 2007;9(1):88–93.CrossRefPubMedGoogle Scholar
  46. Salas RE, Gamaldo CE, Allen RP. Update in restless legs syndrome. Curr Opin Neurol. 2010;23(4):401–6.PubMedPubMedCentralGoogle Scholar
  47. Scholz H, Benes H, Happe S, Bengel J, Kohnen R, Hornyak M. Psychological distress of patients suffering from restless legs syndrome: a cross-sectional study. Health Qual Life Outcomes. 2011;9:73.CrossRefPubMedPubMedCentralGoogle Scholar
  48. Silver N, Allen RP, Senerth J, Earley CJ. A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome. Sleep Med. 2011;12(5):440–4.CrossRefPubMedGoogle Scholar
  49. Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, Palsson S, Sigmundsson T, Sigurdsson AP, Eiriksdottir I, Soebech E, Bliwise D, Beck JM, Rosen A, Waddy S, Trotti LM, Iranzo A, Thambisetty M, Hardarson GA, Kristjansson K, Gudmundsson LJ, Thorsteinsdottir U, Kong A, Gulcher JR, Gudbjartsson D, Stefansson K. A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007;357(7):639–47.CrossRefPubMedGoogle Scholar
  50. Trenkwalder C, Högl B, Benes H, Kohnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med. 2008;9(5):572–4.CrossRefPubMedGoogle Scholar
  51. Trenkwalder C, Beneš H, Grote L, García-Borreguero D, Högl B, Hopp M, Bosse B, Oksche A, Reimer K, Winkelmann J, Allen RP, Kohnen R. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 2013;12(12):1141–50.CrossRefPubMedGoogle Scholar
  52. Trenkwalder C, Winkelmann J, Inoue Y, Paulus W. Restless legs syndrome-current therapies and management of augmentation. Nat Rev Neurol. 2015;11(8):434–45.CrossRefPubMedGoogle Scholar
  53. Vogl FD, Pichler I, Adel S, Pinggera GK, Bracco S, De Grandi A, Volpato CB, Aridon P, Mayer T, Meitinger T, Klein C, Casari G, Pramstaller PP. Restless legs syndrome: epidemiological and clinicogenetic study in a South Tyrolean population isolate. Mov Disord. 2006;21(8):1189–95.CrossRefPubMedGoogle Scholar
  54. Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO. Impulse control disorders and levodopa-induced dyskinesias in Parkinson’s disease: an update. LancetNeurol. 2017;16(3):238–50.Google Scholar
  55. Walters AS. Is there a subpopulation of children with growing pains who really have restless legs syndrome? A review of the literature. Sleep Med. 2002;3(2):93–8.CrossRefPubMedGoogle Scholar
  56. Winkelman JW, Redline S, Baldwin CM, Resnick HE, Newman AB, Gottlieb DJ. Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study. Sleep. 2009;32(6):772–8.CrossRefPubMedPubMedCentralGoogle Scholar
  57. Winkelman JW, Armstrong MJ, Allen RP, Chaudhuri KR, Ondo W, Trenkwalder C, Zee PC, Gronseth GS, Gloss D, Zesiewicz T. Practice guideline summary: treatment of restless legs syndrome in adults: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2016;87(24):2585–93.CrossRefPubMedPubMedCentralGoogle Scholar
  58. Winkelmann J, Schormair B, Xiong L, Dion PA, Rye DB, Rouleau GA. Genetics of restless legs syndrome. Sleep Med. 2017;31:18–22.CrossRefPubMedGoogle Scholar
  59. Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath. 2012;16(4):987–1007.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Neurology and Sleep Disorders CentreGuy’s and St Thomas’ NHS Foundation TrustLondonUK

Personalised recommendations